Novel Cancer Vaccine Prevents Melanoma From Returning in First for mRNA - WSJ


8/19/2026

Novel Cancer Vaccine Prevents Melanoma From Returning in First for mRNA  WSJModerna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%  CNBCModerna, Merck mRNA cancer vaccine prevents melanoma from returning  The HillModerna shares surge as melanoma vaccine with Merck succeeds in large trial  CNNMerck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melano  Business Wire...

Original

Tags: as | cancer | first | for | in | shares | shows | stage | stock | surge | trial | with | wsj



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top